Anti-Human CXCR5 Therapeutic Antibody (m2C9)

This antibody that specifically binds to human CXCR5 may be used for the treatment of rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, and other B-cell-dependent autoimmune diseases.
Supplier Creative Biolabs
Product # TAB-161MZ
Pricing Inquiry
Applications ELISA, FC, FuncS, Inhib
Host Mouse
Target CXCR5 (also known as Burkitt lymphoma receptor (BLR1), CD185, MDR15 and MGC117347) MGC117347
Feedback